FDAnews Device Daily Bulletin

Johnson & Johnson Buys Synthes for $21.3 Billion to Boost Trauma Products

April 29, 2011
A A
Johnson & Johnson agreed to buy Synthes for $21.3 billion in the biggest purchase of the company’s 125-year history, to become the leader in the $5.5 billion market for devices that treat trauma victims.
Bloomberg